corporate overview brochures publications contact us
Quality Assurance
cGMP PHASE I AND PHASE II CLINICAL TRIAL MATERIAL:
Flawless clinical supply manufacturing means getting to market faster.
Formulation Development
  • Dosage Forms
    • Solids – Tablets, Capsules, Multi-particulates, Powders
    • Liquids – Solutions and Suspensions
    • Semi-Solids – Creams, Lotions, Gels, and Ointments
    • Unique Delivery Systems
  • Capabilities
    • Blending
    • Sizing/Milling
    • High Shear and Fluid Bed Granulation
    • Tableting
    • Encapsulation
    • Extrusion/Spheronization
    • Tablet coating
    • Multiparticulate and powder coating
    • Lyophilization
    • Solvent Handling
    • Controlled Substances (Schedule II – V)
    • Low and Intermediate Potency
  • Expertise
    • Controlled Release
    • Solubility Enhancement
    • High and Low Doses
    • Taste-Masking
    • Drug-Layering
    • Orally Disintegrating and Chewable Tablets


EMERSON IN ACTION


IN THE NEWS